Abstract

Responses to transforming growth factor beta and multiple cytokines involve activation of transforming growth factor beta-activated kinase-1 (TAK1) kinase, which activates kinases IkappaB kinase (IKK) and MKK3/6, leading to the parallel activation of NF-kappaB and p38 MAPK. Activation of TAK1 by autophosphorylation is known to involve three different TAK1-binding proteins (TABs). Here we report a protein phosphatase subunit known as type 2A phosphatase-interacting protein (TIP) that also acts as a TAB because it co-precipitates with and directly binds to TAK1, enhances TAK1 autophosphorylation at unique sites, and promotes TAK1 phosphorylation of IKKbeta and signaling to NF-kappaB. Mass spectrometry demonstrated that co-expression of TAB4 protein significantly increased phosphorylation of four sites in TAK1, in a linker region between the kinase and TAB2/3 binding domains, and two sites in TAB1. Recombinant GST-TAB4 bound in an overlay assay directly to inactive TAK1 and activated TAK1 but not TAK1 phosphorylated in the linker sites, suggesting a bind and release mechanism. In kinase assays using TAK1 immune complexes, added GST-TAB4 selectively stimulated IKK phosphorylation. TAB4 co-precipitated polyubiquitinated proteins dependent on a Phe-Pro motif that was required to enhance phosphorylation of TAK1. TAB4 mutated at Phe-Pro dominantly interfered with IL-1beta activation of NF-kappaB involving IKK-dependent but not p38 MAPK-dependent signaling. The results show that TAB4 binds TAK1 and polyubiquitin chains to promote specific sites of phosphorylation in TAK1-TAB1, which activates IKK signaling to NF-kappaB.

Highlights

  • Inflammatory cytokines tumor necrosis factor ␣ and IL-1␤ activate cellular pathways involved in cell proliferation and apoptosis

  • TAB1 is the primary TAK1 activator; it is a substrate for TAK1 (11, 12, 14)

  • TAB2 and TAB3 are unrelated in sequence to TAB1 and bind to a different region of TAK1 near the C terminus

Read more

Summary

Introduction

Inflammatory cytokines tumor necrosis factor ␣ and IL-1␤ activate cellular pathways involved in cell proliferation and apoptosis. The IKK complex consists of IKK␣ and IKK␤, the two catalytic subunits, and the regulatory subunit IKK␥ (known as NEMO), which binds polyubiquitin chains and is ubiquitinated itself (4). The second complex, TRIKA2, contains TAK1, TAB1 (TAK1 activator), and TAB2/3 (ubiquitin-binding proteins) (8, 9). TAB2 and TAB3 activate TAK1 indirectly by binding polyubiquitinated proteins, possibly stabilizing a larger complex (15–19). Studies of the TOR pathway in yeast led to the discovery of Tap, a protein that binds all of the yeast type 2A phosphatases: Sit (PP6), Pph, and Pph21/22 (PP2A) (23). One group claims Tap is phosphorylated directly by TOR to increase Tap binding to Pph21/22 or Sit (24, 25) Another group suggests that Tap is restricted from binding to phosphatases by instead binding a protein called Tip (Tap42-interacting protein of 41 kDa) and that the Tip41-

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call